John Pigott, MD, FACS, Medical Director of ProMedica Innovations, and Founder of VentureMed Group.
For the past 20 years, Dr. Pigott has been involved in the endovascular field with more than 50 peer-reviewed publications and presentations. He was an early proponent of minimally invasive endovascular treatment for abdominal aortic aneurysms and served as investigator for more than 25 industry-sponsored clinical trials, including peripheral interventions, aortic endografts and CTO devices as well as drug and gene therapies. With a long-standing interest in the medical device industry and venture capital, Dr. Pigott holds patents and has patents pending for medically-related devices to treat peripheral artery disease and aortic pathologies.
Dr. Pigott earned his medical degree from Medical College of Ohio, Toledo, Ohio, completed a residency in general surgery at Akron City Hospital and a fellowship in vascular surgery at the Mayo Clinic. He is a fellow of the American College of Surgeons and holds members in the Peripheral Vascular Surgery Society, Midwestern Vascular Surgical Society and Ohio State Medical Association.